Patient safety alert – Support to minimise the risk of distress and death from inappropriate doses of naloxone

Click for article

Click for article

A patient safety alert has been issued by NHS England to support providers of NHS funded care to minimise the risk of distress and death caused by inappropriate doses of naloxone.

The new ‘Stage 2: Resource’ alert highlights a number of resources now available to help providers ensure their local protocols and training related to naloxone reflect best practice.

Combination drug shows promise for treating agitation in patients with Alzheimer’s disease

jamaA combination drug treatment can reduce agitation in patients with probable Alzheimer’s disease and is generally well tolerated, preliminary research published in JAMA has shown.

Click for article

Click for article

The phase II double blind randomised clinical trial showed that patients who received the combination dextromethorphan hydrobromide and quinidine sulphate had lower occurrence and severity of agitation than patients who received placebo. This combination is approved in the United States and the European Union for treating pseudobulbar affect, a neurological disorder characterised by uncontrollable episodes of crying.

NEW Medicine Safety app from CPPE

Our thanks to Ciaran Friel of Liverpool Community Health NHS Trust for this news.

The Centre for Pharmacy Postgraduate Education (CPPmedsafetyE) has launched the Medicines Safety app. This is free and funded by Health Education North West. It offers short quizzes for any healthcare professional to test their knowledge on high-risk areas for medicines safety incidents. The topics so far include: Insulin, Allergies, Opioids, Anticoagulation and Medicines safety.

It stimulates further learning so it can be used to generate ideas for CPD portfolios and to improve practice. You can also use it in group learning situations as a starting point for discussion on key safety issues.

Download the app free of charge from the App Store for iPhone/iPad users and from Google Play Store for Android devices.  More topics will be released soon. 

You can also keep up to date with developments at CPPE and get in touch via the following media:  www.cppe.ac.uk/blog or via Twitter at twitter.com/cppeengland

News from NHS Employers

BMA agree to negotiations on junior doctors contract
The BMA Junior Doctors Committee has announced today (22 July 2013) that it is willing to negotiate with employers on a new contract of employment for junior doctors.

Updated guide to community pharmacy published

NHS Employers, the Pharmaceutical Services Negotiating Committee and the General Practitioners Committee of the BMA have published an updated guide to community pharmacy.

Changes to the community pharmacy Medicines Use Review (MUR) service

From 1st July 2012, new data capture requirements for the community pharmacy MUR service will be implemented. There are also planned changes to the requirement to inform the patient’s GP that an MUR has taken place but the implementation of these changes is subject to the amendment of the relevant Directions.

Royal Pharmaceutical Society | Protecting children and young people

Pharmacists have a professional, legal and moral duty to protect children from abuse or neglect and to work with other organisations and authorities to safeguard children.  The purpose of this resource is to provide concise practical information to help pharmacists protect children and young people in the course of their professional practice.

It provides information in three key areas:

• Recognising signs of abuse or neglect
• What to do if abuse or neglect is suspected
• Sources of further information and advice

Click here to view the Protecting Children and Young People quick reference guide »